GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Earnings for GeneDx Holdings Corp. (WGS)
Earnings in 2023 (TTM): $-176,693,000
According to GeneDx Holdings Corp.'s latest financial reports the company's current earnings (TTM) are $-176,693,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of GeneDx Holdings Corp.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-176,693,000 | $-175,767,000 |
| 2022 | $-598,032,000 | $-548,980,000 |
| 2021 | $-245,390,000 | $-245,390,000 |
| 2020 | $-241,340,000 | $-246,436,000 |
| 2019 | $-29,704,000 | $-30,991,000 |